Treace Medical Concepts Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Treace Medical Concepts stock has a consensus rating of "Hold" and an average price target of $4.00. The average 1-year stock price forecast is 13.96% higher than the current stock price, while the lowest is $2.00 (-43.02%) and the highest is $7.00 (+99.43%).

Price Target: $4.00 (+13.96%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$2.00	$4.00	$3.00	$7.00
Change	-43.02%	+13.96%	-14.53%	+99.43%

Analyst Ratings

The average analyst rating for Treace Medical Concepts stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	4	4	4	3	3	3
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	6	6	6	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ben Haynor Lake Street	Lake Street	Buy Reiterates $7	Buy	Reiterates	$7	+99.43%	May 11, 2026
Richard Newitter Truist Financial	Truist Financial	Hold Reiterates $2	Hold	Reiterates	$2	-43.02%	May 11, 2026
Danielle Antalffy UBS	UBS	Hold Maintains $2.5 → $2.25	Hold	Maintains	$2.5 → $2.25	-35.90%	Mar 2, 2026
Rick Wise Stifel Nicolaus	Stifel Nicolaus	Hold Maintains $3	Hold	Maintains	$3	-14.53%	Mar 2, 2026

Financial Forecast

Revenue This Year

206.26M

from 212.69M

-3.02%

from 212.69M

Revenue Next Year

221.81M

from 206.26M

7.54%

from 206.26M

EPS This Year

-0.91

from -0.80

EPS Next Year

-0.90

from -0.91

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	94.42M	141.84M	187.12M	209.36M	212.69M	206.26M
Revenue Growth	64.59%	50.22%	31.92%	11.89%	1.59%	-3.02%
Gross Profit	77.53M	116.31M	151.94M	168.26M	169.75M	161.66M
Gross Margin	82.11%	82.00%	81.20%	80.37%	79.81%	78.38%
Operating Income	-16.51M	-34.84M	-51.43M	-55.69M	-54.15M	-54.26M
Net Income	-20.55M	-42.82M	-49.53M	-55.74M	-59.00M	-58.31M
EPS	-	-	-	-	-0.80	-0.91
Free Cash Flow	-12.13M	-37.19M	-33.12M	-30.04M	-10.09M	-12.00M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	207.0M
Avg	206.3M
Low	204.2M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-2.7%
Avg	-3.0%
Low	-4.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.91
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-